Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Hashimoto, D. [1 ]
Satoi, S. [1 ]
Yamamoto, T. [1 ]
Yamaki, S. [1 ]
Hirooka, S. [1 ]
Ishida, M. [1 ]
Ikeura, T. [1 ]
Sekimoto, M. [1 ]
机构：
[1] Kansai Med Univ, Hirataka, Japan
来源：
PANCREAS | 2021年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer
    Lee, Darren
    Nelson, Bailey
    Rai, Shesh
    Rai, Jayesh
    Wang, Kyle
    Sohal, Davendra
    Olowokure, Olugbenga Olanrele
    Rojan, Adam
    Patel, Sameer H.
    Wilson, Gregory
    Ahmad, Syed A.
    Kharofa, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Neoadjuvant therapy for resectable pancreatic cancer
    Sheikh Hasibur Rahman
    Robin Urquhart
    Michele Molinari
    World Journal of Gastrointestinal Oncology, 2017, (12) : 457 - 465
  • [33] Venous Thromboembolism Prophylaxis During Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer-Is it indicated?
    Krepline, Ashley N.
    Christians, Kathleen K.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Tolat, Parag
    Evans, Douglas B.
    Tsai, Susan
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (05) : 581 - 586
  • [34] Neoadjuvant therapy for resectable pancreatic cancer
    Rahman, Sheikh Hasibur
    Urquhart, Robin
    Molinari, Michele
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (12) : 457 - 465
  • [35] Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
    Cloyd, Jordan M.
    Heh, Victor
    Pawlik, Timothy M.
    Ejaz, Aslam
    Dillhoff, Mary
    Tsung, Allan
    Williams, Terence
    Abushahin, Laith
    Bridges, John F. P.
    Santry, Heena
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [36] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [37] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [38] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [39] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [40] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
12345